Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children
Status:
Terminated
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness, tolerability and safety of oral
topiramate for the preventative management of Cyclic Vomiting Syndrome. It is believed that
topiramate will decrease the frequency, duration and severity of attacks experienced by
children and adolescents with Cyclic Vomiting Syndrome.